Halaven and Alopecia - from FDA reports


Summary

Alopecia is found among people who take Halaven, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Zometa, and have Breast cancer metastatic. This review analyzes which people have Alopecia with Halaven. It is created by eHealthMe based on reports of 1,766 people who have side effects when taking Halaven from FDA , and is updated regularly.

What to expect?

If you take Halaven and have Alopecia, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Halaven and have Alopecia

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 02, 2017

1,766 people reported to have side effects when taking Halaven.
Among them, 44 people (2.49%) have Alopecia


Number of reports submitted per year:

Could Halaven cause Alopecia?

Time on Halaven when people have Alopecia *:

  • < 1 month: 40.0 %
  • 1 - 6 months: 40.0 %
  • 6 - 12 months: 13.33 %
  • 1 - 2 years: 6.67 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Alopecia when taking Halaven *:

  • female: 97.37 %
  • male: 2.63 %

Age of people who have Alopecia when taking Halaven *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.45 %
  • 40-49: 20.69 %
  • 50-59: 34.48 %
  • 60+: 41.38 %

Top conditions involved for these people *:

  • Breast Cancer Metastatic (14 people, 31.82%)
  • Breast Cancer Recurrent (12 people, 27.27%)
  • Breast Cancer (11 people, 25.00%)
  • Metastases To Bone (7 people, 15.91%)
  • Preventive Health Care (5 people, 11.36%)

Top co-used drugs for these people *:

  • Zometa (5 people, 11.36%)
  • Faslodex (4 people, 9.09%)
  • Taxotere (3 people, 6.82%)
  • Neulasta (3 people, 6.82%)
  • Avastin (3 people, 6.82%)

Top other side effects for these people *:

  • Fatigue (13 people, 29.55%)
  • Neuropathy Peripheral (12 people, 27.27%)
  • Nausea (12 people, 27.27%)
  • Agranulocytosis (11 people, 25.00%)
  • Leukopenia (8 people, 18.18%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Alopecia when taking Halaven?

Expand the study to include all drugs with the same ingredients

Alopecia and drugs with ingredients of eribulin mesylate.

Expand the study to include reports from both FDA and eHealthMe

Alopecia and Halaven from FDA and eHealthMe reports

Halaven

Halaven has active ingredients of eribulin mesylate. (latest outcomes from Halaven 1,772 users)

Alopecia

Alopecia (absence of hair from areas of the body) has been reported by people with multiple sclerosis, rheumatoid arthritis, high blood pressure, hepatitis c, high blood cholesterol (latest reports from 92,003 Alopecia patients).

Browse all side effects of Halaven

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Alopecia

Alopecia

Could your condition cause Alopecia

Alopecia

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Halaven and have Alopecia.

Questions to the study

More questions >

User reviews to the study

More reviews >